Capital Asset Advisory Services LLC Genocea Biosciences, Inc. Transaction History

Capital Asset Advisory Services LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.01 - $1.38 $117 - $16,237	-11,766 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$2.06 - $2.82 $24,237 - $33,180	11,766 New	11,766 $28,000
Q1 2021 May 13, 2021	SELL	$2.35 - $4.01 $22,235 - $37,942	-9,462 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$1.91 - $2.67 $18,072 - $25,263	9,462 New	9,462 $23,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Asset Advisory Services LLC with notifications on news.